# US 2019/0376130 A1 · Isothermal methods for amplifying nucleic acid samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0376130 A1
- Document ID: US20190376130A1
- Status: Published application
- Kind: A1
- Application number: 16/509,447
- Filed: 2019-07-11
- Published: 2019-12-12
- Earliest claimed: 2014-07-16
- Assignees: Tangen Biosciences, Inc.
- Applicants: Tangen Biosciences, Inc.
- Inventors: John R. Nobile; John Davidson
- Web page: https://patentgrep.com/patent/US20190376130A1

## CPC

- C12Q 1/6858: Allele-specific amplification
- B01L 7/52: {with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples}
- B01L 7/525: {with physical movement of samples between temperature zones}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE

## Abstract

The description provides two-stage methods of nucleic acid amplification and detection reactions, which are useful for rapid pathogen detection or disease diagnosis. In particular, the description provides a method comprising a first-stage slow rate amplification reaction followed by a plurality of second-stage fast rate amplification reactions that are simultaneously monitored in real-time, and wherein a rapid rate of amplification is indicative of the presence of a site of interest.

## Claims

### Claim at position 1

1-34. (canceled)

### Claim 35

A two-stage multiplexed nucleic acid amplification and real-time detection method comprising a. providing a composition comprising a target nucleic acid template and a combination of site-specific primers that anneal to the target nucleic acid template near a region of interest to be amplified; b. performing a first isothermal reaction to amplify the region of interest, thereby forming a primary amplicon; c. dividing (b) into at least two secondary reactions, and including in at least one of the reactions one or more site-specific secondary primer that is complementary to a site-specific primer binding site that may be present within the primary amplicon and defines a site of interest within the region of interest; d. performing a second isothermal reaction (second-stage reaction) thereby accelerating the amplification of the region of interest only if the site-specific primer binding site is complementary to the site-specific primer; and e. detecting and comparing the amplification rates of the at least two secondary reactions, wherein an enhanced relative rate of amplification in the reaction with the secondary primer indicates the presence of the site of interest that is complementary to the secondary primer.

### Claim 36 (depends on 35)

The method of claim 35, wherein in step e), the detecting and comparing is in real time.

### Claim 37 (depends on 36)

The method of claim 36, wherein the amplification reaction mixture comprises fluorescently labeled dNTPs, a fluorescent DNA intercalating dye, bioluminescent, chemiluminescent, electrochemical or other reporter system as a means to follow the extent of amplification in real-time.

### Claim 38 (depends on 35)

The method of claim 35, wherein the isothermal nucleic acid amplification method is selected from Nucleic Acid Sequence Based Amplification (NASBA), Transcription Mediated Amplification (TMA), Helicase Dependent Amplification (HDA), Recombinase polymerase amplification (RPA), Strand Displacement Amplification (SDA), Loop-mediated Isothermal Amplification (LAMP), Chimera Displacement Reaction (RDC), Isothermal Chimeric Amplification of Nucleic Acids (ICAN), SMart Amplification Process (SMAP), Linear Isothermal Multimerization Amplification (LIMA), or Self Extending Amplification (SEA).

### Claim 39 (depends on 35)

The method of claim 35, wherein the first nucleic acid amplification is Loop-mediated Isothermal Amplification (LAMP).

### Claim 40 (depends on 35)

The method of claim 35, wherein step (a) includes a forward and reverse loop-forming primer.

### Claim 41 (depends on 40)

The method of claim 40, wherein step (a) includes a forward and reverse displacement primer.

### Claim 42 (depends on 35)

The method of claim 35, wherein the second isothermal nucleic acid amplification reaction is LAMP-STEM.

### Claim 43 (depends on 35)

The method of claim 35, wherein the primary amplicon is a concatamer.

### Claim 44 (depends on 35)

The method of claim 35, wherein the site-specific primer comprises a 3′ end nucleotide complementary to a mutation, single nucleotide polymorphism (SNP), allele or biomarker on the amplicon.

### Claim 45 (depends on 35)

The method of claim 35, wherein the method comprises dividing (b) into at least an additional secondary reaction, wherein the additional secondary reaction includes a mismatch secondary primer.

### Claim 46 (depends on 45)

The method of claim 45, wherein the mismatch primer comprises a 3′ end nucleotide mismatch or 3′ end nucleotide complementary to an allele, mutation or polymorphism different from the site-specific primer.

### Claim 47 (depends on 35)

The method of claim 35, wherein step (e) comprises detecting and comparing in real-time the amplification rates of all secondary reactions, wherein an enhanced relative rate of amplification as compared to the other two reactions indicates the presence of the site of interest that is complementary to the secondary primer.

### Claim 48 (depends on 36)

The method of claim 36, wherein the mutation, SNP, or biomarker is specific for a genetic disease, a microbe or a virus.

### Claim 49 (depends on 35)

The method of claim 35, wherein the step of performing the second nucleic acid amplification reaction includes amplification in the presence of a fluorescent label or dye, thereby labeling the amplification products.

### Claim 50 (depends on 49)

The method of claim 49, wherein the step of detecting and comparing in real-time the amplification rates includes detecting and comparing a fluorescent signal from each of the reactions.

### Claim 51 (depends on 35)

The method of claim 35, wherein a slow-rate isothermal pre-amplification is performed in the first-stage followed by multiple, discrete second-stage amplification and detection reactions performed in parallel directly on the products from the first-stage primary amplicon amplification product.

### Claim 52 (depends on 35)

The method of claim 35, wherein the first-stage amplification reaction comprises site-specific primers such that a first-stage pre-amplification reaction is selective for a particular site of interest, and only if that site or region exists in the sample will rapid amplification of the template proceed at the second stage amplification reaction.

### Claim 53 (depends on 35)

The method of claim 35, wherein the second-stage amplification reaction comprises multiple site-specific primers.

### Claim 54 (depends on 35)

The method of claim 35, wherein an amount or volume of the first-stage reaction is introduced directly into a plurality of second reaction chambers.

### Claim 55 (depends on 35)

The method of claim 35, further comprising the steps of providing a first reaction chamber; performing a first-stage pre-amplification reaction in the first reaction chamber; introducing an amount or volume of the first-stage pre-amp reaction directly into a plurality of second reaction chambers, wherein at least one second reaction chamber comprises a site-specific primer, and at least one second reaction chamber comprises a mismatched primer; and performing in each second reaction chamber a second-stage amplification reaction.

### Claim 56 (depends on 35)

The method of claim 35, wherein the first-stage and second-stage amplification reactions are performed sequentially in the same reaction container or chamber.

### Claim 57 (depends on 35)

The method of claim 35, wherein the target nucleic acid template is nested within a larger amplified region.

### Claim 58 (depends on 35)

The method of claim 35, wherein the first-stage amplification reaction comprises site-specific primers such that the first-stage amplification reaction is selective for a particular site of interest, and wherein only if that site or region exists in the sample will rapid amplification of the template proceed at the second-stage amplification reaction.
